✦ LIBER ✦

Future perspectives for insulinotropic agents in the treatment of type 2 diabetes–DPP-4 inhibitors and sulphonylureas

✍ Scribed by B. Gallwitz; H.-U. Häring

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Piperidinyl-2-phene

✍ John W. Benbow; et al. et al. 📂 Article 📅 2009 🏛 John Wiley and Sons ⚖ 13 KB 👁 1 views

Erratum to: Saxagliptin: a New DPP-4 inh

✍ Abd A. Tahrani; Milan K. Piya; Anthony H. Barnett 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 99 KB

Are Sulfonylureas Less Desirable Than DP

✍ Bo Ahrén 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 233 KB

Dipeptidyl peptidase-4 inhibitors in the

✍ C. F. Deacon 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 711 KB

The oral DPP-4 inhibitor linagliptin sig

✍ T. Forst; B. Uhlig-Laske; A. Ring; A. Ritzhaupt; U. Graefe-Mody; K. A. Dugi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 578 KB

3-[2-((2S)-2-Cyano-pyrrolidin-1-yl)-2-ox

✍ Weir-Torn Jiaang; et al. et al. 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 24 KB 👁 1 views